Ramesh Bista
Ramesh Bista has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Adrian T. Keatinge-Clay
UT Austin
2 shared publications - Jie Zhang
Department of Molecular Biosciences
1 shared publication - Takeshi Miyazawa1 shared publication
Latest Publications
- Open Access
- 29 June 2026
- Published by Springer Nature in Nature Synthesis
- Vol. 5 (11) , 1736-1747
Refactoring pikromycin synthase for the modular biosynthesis of macrolide antibiotics in E. coli
While engineering modular polyketide synthases (PKSs) using the recently updated module boundary has yielded libraries of triketide–pentaketides, this strategy has not yet been applied to the combinatorial biosynthesis of macrolactones or macrolide antibiotics. Here we developed a two-plasmid system for the construction and expression of PKSs and used it to obtain a refactored pikromycin PKS in E scherichia coli that produces 49 mg of narbonolide per litre of culture. The replacement, insertion, deletion and mutagenesis of modules enabled access to hexaketide, heptaketide and octaketide derivatives. Supplying enzymes for desosamine biosynthesis and transfer enabled production of narbomycin, pikromycin, YC-17, methymycin and five derivatives thereof. By using native docking domains, knocking out pathways competing with desosamine biosynthesis and supplying the editing thioesterase PikAV, the titre of narbomycin was boosted 58-fold to 37 mg l −1 . The second and third modules of the refactored pikromycin synthase were swapped with others to yield three new narbomycin analogues, investigate structure–activity relationships and demonstrate how libraries of macrolide antibiotics can be readily accessed.
- 29 June 2026
- Published by Springer Nature in Nature Synthesis
- Vol. 5 (11) , 1736-1747
Open AccessRefactoring pikromycin synthase for the modular biosynthesis of macrolide antibiotics in E. coli
While engineering modular polyketide synthases (PKSs) using the recently updated module boundary has yielded libraries of triketide–pentaketides, this strategy has not yet been applied to the combinatorial biosynthesis of macrolactones or macrolide antibiotics. Here we developed a two-plasmid system for the construction and expression of PKSs and used it to obtain a refactored pikromycin PKS in E scherichia coli that produces 49 mg of narbonolide per litre of culture. The replacement, insertion, deletion and mutagenesis of modules enabled access to hexaketide, heptaketide and octaketide derivatives. Supplying enzymes for desosamine biosynthesis and transfer enabled production of narbomycin, pikromycin, YC-17, methymycin and five derivatives thereof. By using native docking domains, knocking out pathways competing with desosamine biosynthesis and supplying the editing thioesterase PikAV, the titre of narbomycin was boosted 58-fold to 37 mg l −1 . The second and third modules of the refactored pikromycin synthase were swapped with others to yield three new narbomycin analogues, investigate structure–activity relationships and demonstrate how libraries of macrolide antibiotics can be readily accessed.
- 22 April 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (17) , 18322-18333
Engineered Modular Polyketide Synthases Elucidate How Enoylreductases Collaborate with Downstream Acyl Carrier Proteins and Ketosynthases to Set Stereocenters
To engineer modular polyketide synthases that reliably yield stereocomplex products, a detailed understanding of how their enzymatic domains collectively operate is essential. How their enoylreductase (ER) domains function to install either d-or l-oriented alkyl substituents remains largely mysterious. In this study, we investigated the stereoselectivity of ERs and how they work with other domains within tetraketide-heptaketide synthase platforms constructed from components of the pikromycin and rapamycin synthases. We first determined how ER and acyl carrier protein (ACP) domains associate by mutagenically probing the consensus solution predicted by AlphaFold using an in vitro tetraketide synthase platform. Since ERs were found to contact residues conserved in ACPs from diverse module types, we tested whether ERs operate when inserted into modules that only contain ketoreductase and dehydratase domains in several in vivo platforms. ER-inserted modules were observed to generate both unsaturated and saturated intermediates. Increased production of the saturated intermediate was realized when the downstream KS was also swapped for a KS from an ER-containing module. To access products with desired methyl group orientations, it was necessary to consider how the methyl groups interact with the KS of the module that installed them, as well as with the KS of the downstream module. Additionally, we interconverted d- and l-type ERs by swapping a 14-residue loop and propose the molecular basis for how ERs set stereocenters. This research provides new strategies for controlling the orientations of alkyl substituents in complex polyketides and enables access to stereochemical libraries of polyketide drug leads.
- 22 April 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (17) , 18322-18333
Engineered Modular Polyketide Synthases Elucidate How Enoylreductases Collaborate with Downstream Acyl Carrier Proteins and Ketosynthases to Set Stereocenters
To engineer modular polyketide synthases that reliably yield stereocomplex products, a detailed understanding of how their enzymatic domains collectively operate is essential. How their enoylreductase (ER) domains function to install either d-or l-oriented alkyl substituents remains largely mysterious. In this study, we investigated the stereoselectivity of ERs and how they work with other domains within tetraketide-heptaketide synthase platforms constructed from components of the pikromycin and rapamycin synthases. We first determined how ER and acyl carrier protein (ACP) domains associate by mutagenically probing the consensus solution predicted by AlphaFold using an in vitro tetraketide synthase platform. Since ERs were found to contact residues conserved in ACPs from diverse module types, we tested whether ERs operate when inserted into modules that only contain ketoreductase and dehydratase domains in several in vivo platforms. ER-inserted modules were observed to generate both unsaturated and saturated intermediates. Increased production of the saturated intermediate was realized when the downstream KS was also swapped for a KS from an ER-containing module. To access products with desired methyl group orientations, it was necessary to consider how the methyl groups interact with the KS of the module that installed them, as well as with the KS of the downstream module. Additionally, we interconverted d- and l-type ERs by swapping a 14-residue loop and propose the molecular basis for how ERs set stereocenters. This research provides new strategies for controlling the orientations of alkyl substituents in complex polyketides and enables access to stereochemical libraries of polyketide drug leads.